BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16555338)

  • 1. Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study.
    Cescon M; Grazi GL; Grassi A; Ravaioli M; Vetrone G; Ercolani G; Varotti G; D'Errico A; Ballardini G; Pinna AD
    Liver Transpl; 2006 Apr; 12(4):628-35. PubMed ID: 16555338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy.
    Koneru B; Fisher A; He Y; Klein KM; Skurnick J; Wilson DJ; de la Torre AN; Merchant A; Arora R; Samanta AK
    Liver Transpl; 2005 Feb; 11(2):196-202. PubMed ID: 15666380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global gene expression profiles of ischemic preconditioning in deceased donor liver transplantation.
    Raza A; Dikdan G; Desai KK; Shareef A; Fernandes H; Aris V; de la Torre AN; Wilson D; Fisher A; Soteropoulos P; Koneru B
    Liver Transpl; 2010 May; 16(5):588-99. PubMed ID: 20440768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
    Yagci G; Fernandez LA; Knechtle SJ; D'Alessandro AM; Chin LT; Musat AI; Lucey MR; Said A; Pirsch JD; Leverson G; Kalayoglu M
    Transplant Proc; 2008; 40(1):219-23. PubMed ID: 18261591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ischemic preconditioning in rat liver graft.
    Zhang SJ; Chen S
    Transplant Proc; 2004 Sep; 36(7):1970-2. PubMed ID: 15518714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Panax notoginseng saponins preconditioning protects rat liver grafts from ischemia/reperfusion injury via an antiapoptotic pathway.
    Zhang Y; Ye QF; Lu L; Xu XL; Ming YZ; Xiao JS
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):207-12. PubMed ID: 15908317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile duct exclusion from selective vascular inflow occlusion in rat liver: role of ischemic preconditioning and N-acetylcysteine on hepatic reperfusion injury.
    Montero EF; Quireze C; d'Oliveira DM
    Transplant Proc; 2005; 37(1):425-7. PubMed ID: 15808665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemic preconditioning fails to improve microcirculation but increases apoptotic cell death in experimental pancreas transplantation.
    Drognitz O; Liu X; Obermaier R; Neeff H; von Dobschuetz E; Hopt UT; Benz S
    Transpl Int; 2004 Jul; 17(6):317-24. PubMed ID: 15221122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemic preconditioning of cadaver donor livers protects allografts following transplantation.
    Jassem W; Fuggle SV; Cerundolo L; Heaton ND; Rela M
    Transplantation; 2006 Jan; 81(2):169-74. PubMed ID: 16436958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of steatotic graft in living-donor liver transplantation.
    Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
    Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of donor cardiopulmonary arrest in human liver transplantation: possible role of ischemic preconditioning.
    Totsuka E; Fung JJ; Urakami A; Moras N; Ishii T; Takahashi K; Narumi S; Hakamada K; Sasaki M
    Hepatology; 2000 Mar; 31(3):577-80. PubMed ID: 10706545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of cold and warm ischemia time on postoperative graft outcome in human liver transplantation.
    Totsukali E; Fung JJ; Ishizawa Y; Nishimura A; Ono H; Toyoki Y; Narumi S; Hakamada K; Sasaki M
    Hepatogastroenterology; 2004; 51(59):1413-6. PubMed ID: 15362766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of L-arginine against ischemia-reperfusion injury in non-heart beating rat liver graft.
    Gong J; Lao XJ; Zhang SJ; Chen S
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):481-4. PubMed ID: 18842493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of NF-kappaB as effector of IPC in donor livers before liver transplantation in rats.
    Li XC; Ma YF; Wang XH
    Transplant Proc; 2006 Jun; 38(5):1584-7. PubMed ID: 16797362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired hepatic regeneration by ischemic preconditioning in a rat model of small-for-size liver transplantation.
    Yao A; Li X; Pu L; Zhong J; Liu X; Yu Y; Zhang F; Kong L; Sun B; Wang X
    Transpl Immunol; 2007 Jul; 18(1):37-43. PubMed ID: 17584601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ischemic preconditioning on the genomic response to reperfusion injury in deceased donor liver transplantation.
    Jassem W; Fuggle S; Thompson R; Arno M; Taylor J; Byrne J; Heaton N; Rela M
    Liver Transpl; 2009 Dec; 15(12):1750-65. PubMed ID: 19938126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable activation of phosphoinositide 3-kinase influences the response of liver grafts to ischemic preconditioning.
    Cescon M; Carini R; Grazi G; Caraceni P; Alchera E; Gasloli G; Ravaioli M; Tuci F; Imarisio C; Dal Ponte C; Pertosa AM; Bernardi M; Pinna AD; Albano E
    J Hepatol; 2009 May; 50(5):937-47. PubMed ID: 19303157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation.
    Hilmi I; Horton CN; Planinsic RM; Sakai T; Nicolau-Raducu R; Damian D; Gligor S; Marcos A
    Liver Transpl; 2008 Apr; 14(4):504-8. PubMed ID: 18383079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation using uncontrolled non-heart-beating donors under normothermic extracorporeal membrane oxygenation.
    Jiménez-Galanes S; Meneu-Diaz MJ; Elola-Olaso AM; Pérez-Saborido B; Yiliam FS; Calvo AG; Usera MA; González MC; González JC; González EM
    Liver Transpl; 2009 Sep; 15(9):1110-8. PubMed ID: 19718635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.